← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
HP restored modest top-line growth, but profit and free cash flow weakened and an unresolved IT-control material weakness qualified the personal-systems and printing recovery.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 3.2%OK
- Profitability — Net income declined 8.9% to $2.529B from $2.775BWatch
- Cash flow — Free cash flow declined 11.3% to $2.8B from $3.157BWatch
- Margins — Operating margin contracted 139 bps to 5.74%Watch
- Accounting — Revenue growth with material control weaknessNote
- Insiders — 0 purchases and 7 salesNote
Business
HP sells personal computers, workstations, peripherals, printers and printing supplies worldwide.
Where the revenue comes from
Fiscal 2025, as HP INC reports it. History and quarterly detail are in the app.
- Personal Systems$38.5B
- Printing$16.7B
- Corporate Investments$62.0M
Leadership changes
From HP INC's own filings, the day they're filed.
- Ketan Patel · President · appointmenteff. 2025-11-01
- Alex Cho · President · departureeff. 2025-11-01
- Stephanie Liebman · Chief Accounting Officer · departureeff. 2025-09-12
Latest filings
- 10-Q · Quarterly report2026-08-27
- 8-K · Company announcement2026-08-26
- 8-K · Company announcement2026-06-26
- 10-Q · Quarterly report2026-05-28
- 8-K · Company announcement2026-05-27
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about HP INC, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.